• SENSEX 74,764.23
    -813.35 (--1.08%)
  • BANKNIFTY 56,777.55
    -310.75 (--0.54%)
Back

Corporate News

Panacea Biotec shareholders to vote on director reappointment and new Independent Director
07-Sep-2026, 08:58

Panacea Biotec is seeking shareholder approval for the reappointment of directors Ankesh Jain and Harshet Jain, who are retiring by rotation. Ankesh Jain, son of Chairman & MD Dr. Rajesh Jain, and Harshet Jain, brother of Ankesh Jain, both hold no shares in the company. The board also proposes the appointment of Rajinder Singh Manku as a non-executive Independent Director for five years, beginning July 1, 2026. Shareholders will also ratify the remuneration of M/s. [Cost Auditor Name] for the audit year 2026-27, totaling Rs 125,000 plus applicable taxes. Key financial information reveals Ankesh Jain’s remuneration at Rs 0.53 million and Harshet Jain’s at Rs 3.64 million for fiscal year 2025-26. Ankit Jain serves as General Manager – Legal and Company Secretary, based in New Delhi.